Official opening of the MabMine antibody discovery platform at KUL
Month: May 2025
On the 27th of May was the official opening of the novel MabMine antibody discovery platform at Campus Gasthuisberg in Leuven with the participation of about 60 invited academic and industrial collaborators.
The new facility is dedicated to advancing the MabMine antibody discovery platform and is equipped with state-of-the-art technology for:
-
Single B cell screening and isolation;
-
B cell receptor (BCR) sequencing;
-
Recombinant antibody production
-
Antibody characterization.
New Lab Supported by Vlaamse Veerkracht/ NextGenerationEU Grant — PharmAbs
B-specific projects were also highlighted at the event!
Amanda Foks will participate in the Dutch CardioVascular Alliance Leadership Program
Month: May 2025
B-specific coordinator Amanda Foks, has been selected to join the Dutch CardioVascular Alliance (DCVA) Leadership Program 2025-2026. As part of the program, Amanda will work together with fellow scientists, clinicians and DCVA partners on current challenges in cardiovascular research, care and policy. Amanda is very excited to join this program and to contribute to the mission of the DCVA.
More information about the DCVA can be found via this link: https://dcvalliance.nl/
Maaike Cockx participated in the Biosensors Congress 2025
Month: May 2025
The ULUND Team at the Immunotalks Seminar
Month: May 2025
On the 18th May 2025, Anthi Chalou from ULUND team presented her work at the Lund Immunotalks seminar, Lund, Sweden
Event website: https://lit.blogg.lu.se/2025/11/17/lit-seminar-november-18th/
Participation of KUL at Knowledge for Growth 2025
Month: May 2025
During the conference Knowledge for Growth (May 8, 2025 Antwerp, Belgium) https://kfg2020.app.swapcard.com/event/knowledge-for-growth-2025 , Nick Geukens (KUL) gave a talk entitled: Translating Academic Science into Solutions: Antibody Innovations for Tomorrow’s Healthcare.
Visit here TTO Flanders elevator pitch session: research to business
